“showed a trend”

In the subtype analysis, gastric cancer showed a trend consistent with M1, but with higher overall values; AI assistance significantly improved both sensitivity (86.73%) and accuracy (89.85%) (both p< 0.05).

Our hypothesis was also supported by the finding that CD304, one of the surface antigens of pDC, showed a trend towards higher gene expression levels after incubation in the HC group compared to the placebo group (p=0.05).

Of these genes, 11 showed a trend for differential expression between KdVS and controls ( p -value < 0.05; C5orf49, CLCN4 , DMD , RBBP7, TBX2, USP9X, FAM78B, TIMP2, TLE4, ZNF717 and TIGD5 ; Fig.

Furthermore, out of the suggested loci found to be promising candidates for the antidepressant response in clinical applications after validation 34 , multiple SNPs at ABCB1, BDNF, CYP2C19, SLC6A2, CYP2D6 , and HTR2A showed a trend for influencing antidepressant response at a nominal significance in our study ( P < 0.05) (Table S17 ).

In regard to the innate immune-related cytokines, rBCG-ECD003 showed a trend to induce higher IL-17 ( p < .05) and GM-CSF ( p < .01) levels compared to BCG groups at the 4 th week, but not shown at the 12 th week.

All patients showed a trend to lower blood pressure, SVR, and inotropy (P<0.05), but HR, SV, and CO returned to baseline values after 6 weeks treatment (P>0.05).

This was significantly lower than the bacterial load in the D90F group (5.62 log 1 0 CFU/g; p = 0.02) and showed a trend towards superiority over the D90C group (5.87 log 1 0 CFU/g; p = 0.05).

Those who received PepCan and experienced non-recurrence showed a trend of having higher new peripheral T cell immune responses to human papillomavirus type 16 E6 ( p = 0.05).

Those who carried a genotype with the variant C at rs56156320 showed a trend for higher FSCN1 expression, compared with the wild-type homozygous genotypes ( p < 0.05, Fig. 1 ).

For instance, when exposed to a combination of MAP and S-200, NodB genes in CANT-HYD showed a trend similar to that of nahAa and nahAb (naphthalene 1,2-dioxygenase) predicted by PICRUSt2, with a slight decrease in abundance compared to the oil-only group (p < 0.05, one-way ANOVA; p < 0.05, t-test).

The litter C:N ratio showed a trend of decreasing and then increasing with increasing sampling time at 6 and 10 years of recovery, and the value in October was markedly ( P< 0.05) greater than that in May ( Figure 5B ).

Conditions that showed a trend ( p ≥ 0.05 and p < 0.1) of sustaining breastfeeding were a history of non-obstetric complications, initiation of prenatal care in the second trimester (compared to not having prenatal care), and receiving BMSs and maternal breast milk as food upon leaving the hospital (compared to receiving BMSs only).

Analysis of our data did not reveal a statistically significant association between physical or mental multimorbidity and rates of irreversible organ damage (SDI ≥ 1), although the total number of physical comorbidities showed a trend for correlation with the SDI (Spearman’s rho = 0.126, p = 0.050).

ANG-1 showed a trend towards significantly shorter TTSP in patients with a FC ≥1.3 ( p = 0.0501).

At three months, the combination group showed a trend toward lower PPBG levels, approaching statistical significance (p = 0.0501).

The interaction between the condition and the number of questions responded showed a trend, F (1,38) = 4.094, p = 0.0501, η 2 = 0.083, such that question answering in the Expressive condition was related to correct identification of target words, while question answering was not related to correct identification of words in the Flat condition.

When comparing the two cohorts at the most recent FU, the reduction in MRC score observed in the Kim's protocol cohort showed a trend toward statistical significance compared to the relapse cohort ( p = 0.0501; Table 2 ). 3.2.2 INCAT disability scale In the relapse cohort we observed a significant reduction in INCAT scores at the FU timepoint compared to the pre-RTX scores (2.58 ± 1.17 vs. 3.21 ± 1.31; p < 0.05; Table 2 ; Figure 1 ).

The exponential curve of NfL plasma concentrations with age showed a trend of being steeper for males than for females (ratio of ratios = 1.00487, 95% CI: [1.00000, 1.00976], p = 0.0502), with an estimated difference per year of 2.775% (95% CI: [2.388%, 3.164%], p < 2.220 × 10 −16 ) for males compared to an estimated difference per year of 2.277% (95% CI: [1.965%, 2.590%], p < 2.220 × 10 −16 ) for females ( Figure 2 C).

Among these, only anti-Parkinson drugs showed a trend toward increased use compared with moderately severe ataxia (18.7% versus 33.9%, p = 0.0503).

Notably, DRB1*04:10:03 showed a trend toward increased frequency in the ICI-ILD group (p = 0.0503).

Although the univariate intergroup comparison for the top 20 overlapping clones ( Figure 6H ) showed a trend toward expansion of the overlapping CD8 + clones for patients without relapse ( P = .0503), this difference was significant when tested by MVA ( Table 3 ).

ARM presence was not significantly associated with viral load or mortality, though recurrent CMV reactivation showed a trend toward association ( p = 0.0504).

The type of horse showed a trend in the multivariable analysis, ordinal scale ( p = 0.0643), and was close to significance in the multivariable analysis, nominal scale, ( p = 0.0504) ( Table 2 and Table 5 ).

For example, patients with musculoskeletal irAEs showed a trend towards an improved median PFS of 12 months (95% CI: 5-NA) compared to 5 months (95% CI: 4–8) ( p = 0.0505) in patients with any other irAE and a statistically significant higher PFS compared to patients without irAE (2 months, 95% CI: 1–8) ( p = 0.0068).

The pooled analysis showed a trend toward improved OS with chemo-immunotherapy (pooled HR 0.78, 95% CI 0.61–1.00; p = 0.0505), although the result missed conventional statistical significance and moderate heterogeneity was observed (I 2 = 50.2%) ( Supplementary Table S1 ).